Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolastin in Cystic Fibrosis (CF2)
NCT00486837Phase 2Completed
- Sponsor
- Grifols
- Start
- Dec 2003
- Primary completion
- Jun 2004
01
Overview
A Phase 2 trial of alpha-1-proteinase inhibitor in cystic fibrosis (CF), sponsored by Grifols. Started Dec 2003; status: completed.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00486837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486837.